September 28th, 2009

Philadelphia Inquirer Reports:

Emergent Health Corp. says it is considering a stock split.

The King of Prussia-based company said that, by Oct. 31, it would announce the split ratio, which would be effective for shareholders of record as of Dec. 31.

The regenerative-medicine company said yesterday that it was motivated by a need for increased liquidity, as well as an interest in broadening its shareholder base.

The company has 19.81 million shares outstanding, and market capitalization of $68 million. Its thinly traded shares, which trade over-the-counter, have ranged in price in the last 52 weeks from 15 cents (March 9) to $3.50 (early this afternoon).

Emergent announced last month that it had increased its revenues 82 percent from the first half of 2008 to first half of 2009, and that it hoped to eventually see $20 million.

The development-stage biotechnology venture firm says it is looking to add board members who have knowledge of adult stem cell products.

The company says that it has anti-aging, weight loss and pain relief products in its pipeline. Its existing products include those for weight loss and immune system health. – Roslyn Rudolph